Testimony, Comments, & Letters

The HIV+Hepatitis Policy Institute found over 150 employers and issuers utilizing outside vendors as part of their prescription drug benefit for their employees that designate certain drugs as “non-essential health benefits” to evade ACA cost-sharing requirements. Most of them implement copay maximizers, under which they keep all copay assistance from drug manufacturers rather than applying it to the patient’s out-of-pocket costs. Others use an alternative funding program, in which carved out drugs are sourced from patient assistance programs meant for the uninsured or by drug importation.